Jurisdiction
Israel
21 announced deals involving Israel, most recent first, with the firms that advised on each.
Most recent
SEARCH ALL 21 DLA Piper advises Renovo Capital in sale of Otodata to GI Partners 3 Sept 2026
Latham Advises on Affinity Partners’ Sale of Stake in Phoenix Financial for Over NIS 1 Billion 31 Jul 2026
Latham & Watkins Advises TeamSystem and Hellman & Friedman on €700 Million Senior Secured Notes Offering 9 Jul 2026
Latham Advises on NextVision’s Secondary Placing of Ordinary Shares 30 Jun 2026
Sidley Represents Apono in Its Acquisition by 1Password 17 Jun 2026
Linklaters advises Heidelberger Druckmaschinen AG on German-Israeli-US drone defence joint venture 27 Mar 2026
Latham Advises on Meitav’s US$153 Million Global Offering 5 Dec 2025
Clifford Chance advises Northwind Group on US$340 Million Healthcare Debt Fund II 21 Nov 2025
Sidley Represents Itron in Its US$525 Million Definitive Agreement to Acquire Locusview 18 Nov 2025
Hogan Lovells represents SOCAR in its acquisition of stake in Tamar gas field 7 Jul 2025
Hogan Lovells advises SOCAR on its agreement to acquire a stake in the Tamar gas field, Israel 14 Feb 2025
Baker Botts Advises Modern Times Group on Transformative Plarium Acquisition 15 Nov 2024
Hogan Lovells advises Azerion on sale of Youda games portfolio to Playtika 7 Aug 2023
Sidley Advises Lightspin Technologies in Its Pending Acquisition by Cisco 31 Mar 2023
Latham & Watkins Advises HUB on de-SPAC Business Combination with Mount Rainier Acquisition Corp. 3 Mar 2023
Hogan Lovells advises Covestro on the sale of its Additive Manufacturing business to Stratasys 18 Aug 2022
DLA Piper advises Lionheart III Corp on the first de-SPAC transaction with an Australian public company 5 Aug 2022
Latham & Watkins Advises Francisco Partners on Financing in Connection with SatixFy’s SPAC 11 Mar 2022
Latham & Watkins Advises on Sale of Melsoft Games to Moon Active 23 Dec 2020
Latham & Watkins Advises NeoGames on US$94 Million IPO 24 Nov 2020
Allen & Overy advises Apax Partners and its portfolio company Neuraxpharm on the acquisition of Buccolam® Assets 18 Sept 2020